Procept Biorobotics Corp
PRCT28.740USD
+1.340+4.89%
Fechamento 02/06, 16:00（ET）Cotações atrasadas em 15 min
1.61BValor de mercado
PerdaP/L TTM
Mais detalhes de Procept Biorobotics Corp Empresa
PROCEPT BioRobotics Corporation is a commercial-stage surgical robotics company. The Company is focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AQUABEAM Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia (BPH). The Company's proprietary AQUABEAM Robotic System delivers Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. Aquablation therapy delivers effective, safe and durable outcomes for males suffering from lower urinary tract symptoms (LUTS), due to BPH, which are independent of prostate size and shape or surgeon experience.
Informações de Procept Biorobotics Corp
Código da empresaPRCT
Nome da EmpresaProcept Biorobotics Corp
Data de listagemSep 15, 2021
CEOWood (Larry L)
Número de funcionários756
Tipo de títulosOrdinary Share
Fim do ano fiscalSep 15
Endereço150 Baytech Drive
CidadeSAN JOSE
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal95134
Telefone16502329832
Sitehttps://www.procept-biorobotics.com/
Código da empresaPRCT
Data de listagemSep 15, 2021
CEOWood (Larry L)
Executivos da empresa Procept Biorobotics Corp
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Frederic H. (Fred) Moll, M.D.
Dr. Frederic H. (Fred) Moll, M.D.
Independent Director
Independent Director
863.16K
+20000.00%
Mr. Larry L. Wood
Mr. Larry L. Wood
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
188.36K
+182392.00%
Mr. Taylor C. Harris
Mr. Taylor C. Harris
Independent Director
Independent Director
134.25K
+1538.00%
Mr. Kevin Waters
Mr. Kevin Waters
Executive Vice President, Chief Financial Officer
Executive Vice President, Chief Financial Officer
66.61K
-4415.00%
Mr. Hisham Shiblaq
Mr. Hisham Shiblaq
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
18.05K
--
Ms. Mary Garrett
Ms. Mary Garrett
Independent Director
Independent Director
14.38K
+1538.00%
Ms. Elisabeth Little
Ms. Elisabeth Little
Independent Director
Independent Director
11.02K
+11023.00%
Thomas M. Prescott
Thomas M. Prescott
Independent Chairman of the Board
Independent Chairman of the Board
3.90K
+1538.00%
Ms. Amy M. Dodrill
Ms. Amy M. Dodrill
Independent Director
Independent Director
--
--
Mr. Antal Desai
Mr. Antal Desai
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Frederic H. (Fred) Moll, M.D.
Dr. Frederic H. (Fred) Moll, M.D.
Independent Director
Independent Director
863.16K
+20000.00%
Mr. Larry L. Wood
Mr. Larry L. Wood
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
188.36K
+182392.00%
Mr. Taylor C. Harris
Mr. Taylor C. Harris
Independent Director
Independent Director
134.25K
+1538.00%
Mr. Kevin Waters
Mr. Kevin Waters
Executive Vice President, Chief Financial Officer
Executive Vice President, Chief Financial Officer
66.61K
-4415.00%
Mr. Hisham Shiblaq
Mr. Hisham Shiblaq
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
18.05K
--
Ms. Mary Garrett
Ms. Mary Garrett
Independent Director
Independent Director
14.38K
+1538.00%
Detalhamento da receita
Moeda: USDAtualizado em: ter, 6 de jan
Moeda: USDAtualizado em: ter, 6 de jan
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por EmpresaUSD
Nome
Receita
Proporção
Hand pieces and other consumables
49.73M
59.68%
System sales and rentals
28.14M
33.77%
Service
5.46M
6.55%
Por RegiãoUSD
Nome
Receita
Proporção
United States
73.91M
88.70%
Outside United States
9.41M
11.30%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Hand pieces and other consumables
49.73M
59.68%
System sales and rentals
28.14M
33.77%
Service
5.46M
6.55%
Distribuição de ações
Atualizado em: sáb, 31 de jan
Atualizado em: sáb, 31 de jan
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Fidelity Management & Research Company LLC
14.12%
The Vanguard Group, Inc.
9.29%
BlackRock Institutional Trust Company, N.A.
6.67%
AllianceBernstein L.P.
6.12%
T. Rowe Price Investment Management, Inc.
3.67%
Outro
60.13%
Investidores
Investidores
Proporção
Fidelity Management & Research Company LLC
14.12%
The Vanguard Group, Inc.
9.29%
BlackRock Institutional Trust Company, N.A.
6.67%
AllianceBernstein L.P.
6.12%
T. Rowe Price Investment Management, Inc.
3.67%
Outro
60.13%
Tipos de investidores
Investidores
Proporção
Investment Advisor
65.02%
Investment Advisor/Hedge Fund
32.85%
Individual Investor
4.43%
Research Firm
3.93%
Hedge Fund
2.68%
Bank and Trust
1.11%
Pension Fund
0.76%
Venture Capital
0.66%
Family Office
0.11%
Participação acionária institucional
Atualizado em: qui, 1 de jan
Atualizado em: qui, 1 de jan
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q4
568
59.67M
106.79%
-2.29M
2025Q3
536
55.75M
99.78%
-1.67M
2025Q2
535
55.45M
100.20%
-990.27K
2025Q1
539
53.99M
97.68%
-2.82M
2024Q4
499
53.70M
99.42%
+875.53K
2024Q3
449
49.13M
94.16%
-1.41M
2024Q2
393
47.17M
91.61%
-2.29M
2024Q1
345
48.36M
95.04%
-4.45M
2023Q4
326
47.80M
94.81%
-4.63M
2023Q3
322
46.77M
93.30%
+2.15M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Fidelity Management & Research Company LLC
7.89M
14.12%
+189.04K
+2.45%
Sep 30, 2025
The Vanguard Group, Inc.
5.19M
9.29%
-44.67K
-0.85%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
3.73M
6.67%
-3.85K
-0.10%
Sep 30, 2025
AllianceBernstein L.P.
3.42M
6.12%
+1.26M
+58.55%
Sep 30, 2025
T. Rowe Price Investment Management, Inc.
2.05M
3.67%
+524.77K
+34.35%
Sep 30, 2025
Westfield Capital Management Company, L.P.
1.97M
3.53%
+371.80K
+23.26%
Sep 30, 2025
Mackenzie Investments
1.45M
2.6%
+745.78K
+105.24%
Sep 30, 2025
Champlain Investment Partners, LLC
1.44M
2.57%
+367.25K
+34.30%
Sep 30, 2025
Artisan Partners Limited Partnership
1.37M
2.44%
+378.84K
+38.41%
Sep 30, 2025
State Street Investment Management (US)
1.32M
2.37%
+55.56K
+4.38%
Sep 30, 2025
Ver Mais
ETFs Relacionados
Atualizado em: sáb, 6 de dez
Atualizado em: sáb, 6 de dez
Nome
Proporção
Global X HealthTech ETF
1.64%
State Street SPDR S&P Health Care Equipment ETF
1.62%
ALPS Disruptive Technologies ETF
0.86%
First Trust Nasdaq Lux Digi Health Solutions ETF
0.7%
Global X Robotics & Artificial Intelligence ETF
0.7%
Main Thematic Innovation ETF
0.46%
Harbor Health Care ETF
0.35%
Langar Global HealthTech ETF
0.32%
iShares U.S. Medical Devices ETF
0.22%
Nuveen ESG Small-Cap ETF
0.17%
Ver Mais
Global X HealthTech ETF
Proporção1.64%
State Street SPDR S&P Health Care Equipment ETF
Proporção1.62%
ALPS Disruptive Technologies ETF
Proporção0.86%
First Trust Nasdaq Lux Digi Health Solutions ETF
Proporção0.7%
Global X Robotics & Artificial Intelligence ETF
Proporção0.7%
Main Thematic Innovation ETF
Proporção0.46%
Harbor Health Care ETF
Proporção0.35%
Langar Global HealthTech ETF
Proporção0.32%
iShares U.S. Medical Devices ETF
Proporção0.22%
Nuveen ESG Small-Cap ETF
Proporção0.17%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
